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Hypertrophic scar is the result of abnormal healing 
that often follows thermal injury. Hypertrophic scar 
is characterized by excessive dermal fibrosis and scar-
ring. Five cases of human hypertrophic scar were 
compared with normal skin using in Sitll hybridization 
to localize mRNAs for pr~collagen types I and III and 
transforming growth factor-/31. Expression of type I 
pro collagen and TGF-/31 were also examined with 
iInmunohistochemistry. The results demonstrated a 
significant increase in the expression of mRNA for 
types I and 01 pro collagen and type I pro collagen 
protein by fibroblasts in hypertrophic scar compared 
H ypertrophic scar (HTS) is an excessive healing response that folJows themlal injury, resulting in pathologic dermal fibros is. C lini cally, it is charac-terized by excessive matrix synthesis , persistent scarring, and increased wound contra ction. The 
result is joint contracture with a de fo rmed appearance. HTS is the 
most importan t factor Limiting long-term functional recovery from 
a serio us bum injury [1] . 
T he pathogenesis of H TS is not w e lJ understood . Previous 
studies have suggested different mechanisms for the dennal fibrosis. 
Studies of HTS tissues and cultured H TS fibrobl asts have demon-
strated both increased [2-4] and nonnal [5-7] levels o f collagen 
synthesis when compared to normal dermal fibroblasts in culture. A 
m echanism for apparent in creased m atrix accumulation is suggested 
by work demonstrating decreased collagenase activity in HTS [8,9). 
Degradation of connective tissue durillg wound remodeling may 
a1so be affected by serum protease inhibition [10), or decreased 
coUagen cross-linking [11). T hese results suggest an imbalance 
between collagen synthesis and degradation that resu lts in excessive 
deposition of connective ti ssue matrix in HTS. The mechanism of 
this imbalance may be complex . interpretation of th ese resu lts 
assumes that ill "ilm studies o f cells and tissues accurately re flect 
collagen gene expressio n ill " i"o. 
Dermal fibroblasts from scar and nonnal tissues and extracellular 
matrix compon ents interact through regulatory mediators, includ-
ing cytokine growth factors. Perturbation of nomlal regulatory 
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witb normal skin. In all cases of hypertrophic scar, 
significant numbers of cells expressed TGF-/31 mRNA 
or peptide. Neither TGF-/31 mRNA nor protein was 
detected in control tissues. These results suggest a 
protound increase in production and expression of 
types I and III collagen mRNA by the fibroblasts in 
hypertrophic scar. This may result from increased 
TGf'-/31 production, through paracrine and autocrine 
patltways, as have been described for this fibrogenic 
cytokine. Key lVords: fibrosis/dermal fibroblasts/cytoki1te. 
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sign:;J.is may lead to fibrosis in HTS and other fibroti c skin diseases 
[12-17]. Transforming growth factor f3 (TGF-f3) is a w e ll-described 
prof~brogeni c cytokine that promotes extraceUul ar m atrix accumu-
lation by increasing collagen synthesis and decreasing degradation 
[18] . R ecent studies have suggested that TGF-f3 may be impo rtant 
in tne pathogenesis of H TS [19], although dil:ect e vidence is 
lacld.ng. 
Tnis study addresses th e question of whether collagen and 
TGr-f3 protein and gene expressio n are altered in HTS lesions. T he 
use of ill sil ll hybridization and immunohistochemistry allows direct 
asse5sment of ;11 "illo changes in gene expression and provides 
important clues as to the ti ssue distribution and identity of the cell 
types responsible for the alterations in gene expression. The resul ts 
provide evidence for in creased expression of types J and HI 
procolJagen mRNA and protein as well as TGF-f31 mRNA and 
pepcide in HTS as compared with norma l skin. T he correlation 
betvveen increased TGF-f31 and collagen expression within HTS 
s ug~ests that TGF-f3 may be a ke y m ediator of increased coUagen 
sYlltl1es is in its pathogenesis. 
MATEIUALS AND METHODS 
Tissue Biopsies Five patients with clil~ically severe HTS underwent 
biopSY, T hcse patients had sustained deep partia l- to full - thickness thermal 
burnS ovcr 30-55'Yo of the tota l body surface arca. T hey were fOllr men and 
one woman 18-45 years o ld. T he scars were biopsied 5-18 months 
fo llowing the initial inju ry. All scars we re clinica ll y symptomatic, charac-
tc rized by rcdness, itching, incrcasing size, and /or continued contractio n. 
BioJ'sy specimens were 5-10 mm in diame ter and w cre perfo rmed at the 
time of reconstructive surgery (1R.B-91 - 78) . Biopsied sites included the 
arn1" f.,ce, neck, and chest. The initi al diagnosis of HTS was made clinica lly 
and confmned subsequently based on typ ical characteri sti cs fo r these lcs ions 
[2 0 ~22 1 . In each case, the patients' unburtled skin was used as a control; 
concro l skin was hi stologica lly no rmal. These specimens wcre either fixcd in 
10% ncutr:t1 bufFe red formali n , pH 7.2, for 16 h and embedded in paraffin , 
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or frozen fi'esh and stored in liquid nitrogen . Serial sections from each Case 
were processed fo r immunohistochemistry and ill Sitll hybridization histo-
chemistry. 
Oligonucleotide Probes and Antibodies Complementary 30-base 
oligodeoxynucleotide antisense probes (30 mers) to procollagen types I, III, 
and IV and to TGF-!31 were synthesized by an automated DNA syn thesizel' 
(Gene Assembler) and purified by high-performance liquid chromatography 
before use. T he sequences for these probes were as fo llows: 5' -d (GCA-
GAC_AGG-GCC-AAC-GTG-GAA-GCC-GAA-TTC) for a1(I) procolIa-
gen [23,24)' 5' (AGC-AAT-GGC-AGC-GGC-TCC-AAG-AAC-AA.C-
GCT) for al(lII) procollagen [25] , 5'-d (GAA-GTT-GGC-ATG-GTA-
GCC-CTT-GGG-CTC-GTG) for TGF-!31 [26,27]. 
Mouse monoclonal antibody SP1.D8, wl~ich recognizes the amino-
tenllinus of al (I) procoUagen I [24,28] and was obtained from the Develop-
mental Studies Hybridoma Bank (National Institutes of Health, Bethesda, 
MD). Mouse monoclonal antibody 1Dl1.16 recognizes both TGF-!31 and 
TGF-!32 and was a generous gift of Celtri.x Pharmaceuticals [29]. 
III Sitll Hybridization III sitll hybridization was performed as described 
previously [30,31] . Controls for ill siw hybridization included the foUowi.t1g : 
digestion of RNA by exposing tissue samples to 100 J.Lg/ml of RNAse A 
(Sigma) for 45 min at 37°C before incubation with the antisense probe. a nd 
hybridization substi tuting the corresponding sense probes for the antise11se 
probe. 
IrnJllUnocytochen1istry Lmmunocytochemistry was performed using 
the immunoperoxidase method described previously [24,29]. Negative 
controls consisted of both omitting the primary antibodies and using 
comparable concentrations of nonimmune mouse immunoglobulin instead 
of the primary antibodies. 
Morphometric Analysis Tissue sections were studied with light micros-
copy using the Image 1 computer color image anal ysis system (Unive\csal 
Imaging Corp.) . At least 15 contiguous, nonoverlap ping microscopic fi<'> lds 
of each section were analyzed. For immunohistochemistry data , SP1. D8-
positive ce lls in HTS and control skin were coun ted at a magnificatiol\ of 
400 X. SP1.D8-positive ce ll s were identified as a countersta ined nucl e u s 
associated with' cytoplasm stained positively w ith dark diaminobcnz(!ne 
reaction product. For statistical analysis. we compared the ave rage numb ers 
of SP1.D8-positive cell s per high-power field in HTS and in control skin . 
For the ill sitll hybridiza tion data, nuclei labeled with more than five sil ver 
grains were considered positive. T his criterion eflcctive ly distinguisb,ed 
background signal seen on the control slides using the sense probe. For each 
field examined. both the number of positive ceUs and the intensiry of 
labeling were determined . Intensity of labeling was assessed by measuti.J1g 
the pixel area occupied by silver grains and subtracting it fi'olll backgro~nd 
for each positive ceU per high-power (400 X) field. 
Statistical Analysis Statistica l comparisons of the data were perfon'tled 
using paired Student t tests . A p va lue of less than 0.05 was considered to 
indicate statistically significant diflerences. 
RESULTS 
Localization of Types I and III Collagen mRNA We first 
d e te rmine d th e m echanisms for the increased collagen synthesis by 
assessing coHagen gen e expression. III sitll h ybl'idization w ith probes 
for type a1(1) and a1(III) procollage n mRNA was u sed to inves-
tigate collagen gen e expression in normal skin and in HTS. All 
normal skin samples demonstrated a weak but specifi c hybridi~a­
tion signal to type I proco llagen mRNA, which was localized to 
scattered d e mlal fibroblasts (Fig la) . T h e re was no specific hybli d-
ization sig nal for type III procoUagen mRNA in the n omlal stcin 
(Fig lb) . In HTS tissues, there was a significantly stronger specUlc 
hybridiza tion signal to types a1 (1) and al (IIl) procollagen mR.NA, 
which was localized in numerous fibrob lasts diffusely distributed 
throughout th e scar lesions (Fig lc,d) . Both probes were locali~ed 
in a similar distribution over fibroblasts th roug hout tile del'l1~is . 
These results were specific to d ermal fibrob lasts . No other e U 
types, including e pithelial and e ndothe lial cells, were labeled to)' 
e ithe r type al (I) or a l(llI) mRNA. In som e HTS lesio n s, gro ups of 
fibroblasts cl ustered close to blood vessels h ad a stronger sign al to 
types al (I) and a l (III) procoUagen than t he positively labeled 
fibroblasts di stribute d throug hout the d ermis. Morpho m etric al1,al-
ysis showed a dramatic increase in both the number of positive c~ll s 
(Fig 2) and the overal1 intensity (Table I) of h ybridiza tion sig t\.al. 
N either h ybrid ization with sen se probes for a l (I), a 1 (III) , "-t1d 
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Figure 1. Types I and ill collagen gene expression in HTS and 
nornlal fibroblasts. Biopsy specimens were fixed in fo rmalin and stained 
using ill sitll hybridi zation (400 X). n, Type I collagen expression visualized 
w;th oligonucleotide probe for a J (I) in normal skin. SmaU amounts of 
background are seen in some of the dermal fib roblasts (nn·o,,'s). Bnl', 25 J.Lm . 
ii, Type III co llagen expression visualized with oLigonucleotide probe for 
al (Ill) in nonnal skin . T here is no significant background activiry. Bnl', 25 
J.L1I1). c, Type 1 coUagen e"-pression visualized w ith oligonucleotide probe for 
al (I). Hypertrophic skin shows signifi cantly increased hyb ridi zation signal 
by dermal fib roblasts. Bnl', 50 J.Lm). d, Type III co llagen expression 
visualized Witll oligonucleotide probe for a 1 (Ill). Bnl', 50 J.Lm). 
al (IV) collagen nor hybt;dization Witll antisense probes after 
p retreatm ent w ith RNA se demonstrated hybridization signal above 
background levels (results not shown). T h ese results suggest tllat 
QUANTITATION OF IN SITU HYBRIDI ZATION 
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Figure 2 . Frequency of dermal fibroblasts positive for collagens I 
and ill gene expression b y ill sit" hybridization. Tissue biopsy 
specimens of ,!-ITS and nOl1l1al skin (NS) were probed Witll antisense oligo-
nucleotides for a l (I) and al(lIl) . Morphometric analysis, as described in 
Mnterinls flIId Methods, was used to COllnt cells Witll significant labeling. At least 
15 contiguolls. lion-overlapping fields in each specimen were analyzed. The 
results (::!: SD) represent the number of positive cells per high-power field 
(HPF) (400 X). 
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Table I. Collagen Gene Expression in Skin After 
Thermal Injury" 
Collagen mRNA/Cell 
Type Tissue (/-Lm 2) 
Normal < 1 
HTS 37 .6 







I I Intensity of i" situ hybridizatio n signal for types I and III coll agen. Data represent 
the am ount ofarc:1 of hybridizatio l1 signal per positive ce ll (sec text for details). Image 
3Jl :l lysis was perfo rmed lIsing the IIn:lgc L system (Unj versa i Im ag in g Corp.). 
increased collagen protein in HTS is the direct result of increased 
gene expression. 
Localization ofTGF-13 IIlRNA To determjne the synth esis and 
cellular origin of TGF-{3, we investigated the presence of TGF-/3l 
mRN A in both formalin-fixed .and frozen tissues. [1'1 sit", hybridiza-
tion using the anti-sense probes found no significant hybridization 
signa l in the nonnal skin (Fig 3a). Within fresh-frozen sections of 
HTS, a large number of strongly TGF-{3l-positive cells were 
identified within the dermis (Fig 3b). Formalin-fixed sections 
showed less intense signal but intact tissue architecture. Many of the 
cells expressing TGF-/31 mRNA had plumper or rounder nucle i 
than the fibroblasts, although there were a vari;lbl e number of 
scattered TGF-/3l-positive fibroblast-like cells found in all HTS 
cases. Although the identity of these plumper cells remains unde-
tern1ined, they may represent dendritic ce l.l s or other mononuclear 
phagocytes . Some capillary endothelial cells, and mononuclear cells 
close to capiUari ~s, were also strongly positive for TGF-/3l mRNA 
(Fig 3c) . Epidermal cells harboL;n g TGF-{3 mRNA were fOLIJ1d in 
three of the five cases of HTS. In control experiments, hybridiza-
tion with sense TGF-/31 probe or pretreatment with RNAse 
resulted in background staining only. T hese results dem onstrate 
increased TGF-/31 gene expression by severa l cell types within HTS 
and suggest both autocrine and paracrine roles for TGF-/31 in the 
increased collagen gene expression noted in HTS fibroblasts. 
Localization of Type I Procollagen Alter,lti ons in collagen 
synthesis within HTS lesions were. investigated by staining for 
procollagen protein. Immunohistochemjcal stai ning with anti-pro-
collagen type I (SPl.D8) antibody positively stained the cytoplasm 
of an occasional dermal fibroblast in normal skin, demollStr:ating 
little newly synthesized coHagen. T he results were similar to those 
for collagen gene expression. In contrast, virtually all of the dermal 
fibrobla sts in HTS were strongly positive (Fig 4a,b). T he number 
and distribution of SPl.D8-positive ceJJ s were similar to those 
localized using the type al(I) coHagen antisense probe. An average 
of2 ± 0.15 cells per high-power fie ld were positive in norm al skin 
compared to 25 ± 2.6 in HTS (p < 0.05). No other cell types or 
skin appendages were stained with this antibody. We conclude that 
increased collagen synthesis is a primary cause for increased matrLx 
in HTS lesions. 
Localization of TGF-13 Protein Immunohistochemistry using 
anti-TGF- /3 antibody (lDl1.16) confirmed a role for this cytokine 
in the pathogenesis ofHTS. No positive cells were stain ed with thjs 
antibody in the nonna] control skin (Fig 5a) . In HTS, many 
fibroblast-like cells and some endothelial cell s were positive for 
anti-TGF-J3-like imunoreactivity (Fig 5b). T hese cells were in the 
same locations as those staining for procollagen, suggestin g a 
relation . In addition , we noted significant staining of matrix 
surrounding these cells. 
DISCUSSION 
These results demonstrate a dramatic increase in the expression of 
types al(l) and al(lll) procoll'lgen mRNA and the synth esis of 
type I procollagen protein in HTS in sitH . Active collagen synthesis 
appears to be a critica l fa ctor leadin g to the excessive matrix fo und 
T H E JOUI~AL OF INVESTIGATIVE DERMATOLOGY 
Figure 3. Normal skin and hypertrophic scar probed for TGF-/31 
gene expression using ill sit" hybridization. a, Frozen section of 
normal skin showing background staining only. Bar, 25 /-L1I1 . b, Frozen 
section ofHTS. Although ti ssue architecture is indistinct, specific staining of 
fibroblast nuclei is clearly secn (nITOllls). Bar, 50 /-Lm . c, Formalin-fixed 
section of HTS showing incrcased signal in capillary endothelial cells and 
adjacent fibroblasts (an·OI11s). Bar, 50 /-Lm. 
in HTS. Norn1ally, collagen types I and III are expr:essed in healing 
dermal wounds (3 2,33]. Type III collagen synthesis usually de-
creases early within the fir:st month after injury. The continued 
expression of type III collagen months after initial reepithelializa-
tion and wOLIJ1d healing suggests a prolongation of the normal 
healing sequence. Furthermore, the strong signals for collagen gene 
and pr:ote in activity suggest that the increased accumulation of 
m atrix is due to increased synthesis r:ather than decreased break-
down . 
Other cutaneous fibrotic lesions have been shown to express 
diffe rent types of collagen with distinctive patterns of distribution. 
Different etiologic factors, m echanisms, and locations of injury may 
contribute to the heterogeneity of production and distribution of 
collagen in these fibrotic cutaneous diseases. Other cutaneous 
fibrotic diseases including progressive systemic sclerosis, morphea, 
and eosinophilic fascutis [34,35] each have their own particular 
pattern of collagen gene expression. In tills study of HTS, the 
pattern of distribution of cells positive for collagen types al (I) and 
a l(lII) mRNA was mor:e diffuse than that found in keloid and 
cutan eous neurofibroma [34,36]. In keloids, active collagen gene 
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Figure 4. Immunohistochemical localization of type I procollagcn 
in normal skin and HTS. Primary antibody (SP1.D8, Developmental 
Studies Hybridoma Bank) was visualized with a biotinylated second a.nti-
body, biotin-avidin amplification with 3 ' 3-diaminobenzidine as a chromo -
gen. a, N ormal skin sta ined to visualize the amino-terminus of type I 
procollagen. Bar, 25 f.Lm. IJ, HTS stained to visualize the amino-terminus of 
type I procollagen. Bar, 50 f.Lm. 
expression is localized to fibroblasts found in the expanding borders 
of the lesion . Strongly positive cells that express types al(l) and 
a2(IV) collagen genes are scattered throughout neurofibroma le-
sions. T he findings of collagen al (I) gene expression by endothelial 
cell s in keloids, and of collagen al (IV) gene expression in some 
neurofibroma cells, were not observed in these cases of HTS. 
However, in both HTS and keloids, fibroblast-like cells adjacent to 
small blood vessels showed a greater intensity of collagen gene 
signal. Immunohistochemical staining of HTS with anti-procolla-
gen (SPI.D8) antibody suggests that cells with increased collagen 
type al (I) gene expression also increase type I pro collagen protein 
synthesis. T he presence of many cells actively synthesizing collaget'l 
in HTS supports the hypothesis of altered phenotype of the 
fibroblast cells in HTS. Additional data support this conclusion: 
keloid and HTS fibroblasts have been shown to overexpl'ess 
fibronectin message and protein relative to normal skin fibroblasts 
ill lJilJo and to retain this capability ill lJitl'O [37]. T his m echanistn is 
consistent with other studies from our laboratory [2]. 
Previous studies have suggested a role for TGF-{3 in the patho-
genesis of HTS [2,19]. Those studies documented changes in 
dermal fibroblast phenotype similar to those that would be pre-
dicted after TGF-{3 exposure: decreased repli cation rate, increased 
basal collagen synthesis, and increased rate of contraction of 
Figure 5. Immunohistochemical localization of TGF-/3 in norUla) 
skin and hypertrophic scar. Primary antibody was visuali zed w it h a 
biotinylatcd second-an tibody, biotin-avidin amplification with 3'3-diami_ 
nobcnzidine as a chromogen . a, N ormal skin stained for TGF-/3 using 
lDll .16. T here is only background sta ining. Bar, 50 f.Lm. b, Hypertrophic; 
scar stained for TGF-J3 USiJlg ID11 .16. T here is significant sta.ining of 
dermal fibroblasts and adj acent matrix (lmge arrol/ls) . TGF-{3 immunoreac_ 
tivity is also present in capillary endothelial cell s within the demlis (sma/} 
a/1"OIvs). Bar, 50 f.Lm . 
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fibroblast- populated collagen lattices . In addition , increased levels 
of TGF-{3 activity have been demonstrated in HTS (unpublished 
data). T he present study further supports a ro le for TGF-{3 as a 
mediator of fibrosis in HTS. Both al (I) and al (III) collagens and 
TGF-{31 mRNA production are localized to fibroblast-like cells 
that have a similar pattem of distribution within HTS. Adjacent 
mononuclear cells and endothelial cells also strongly expressed 
TGF-{31 , which suggests a relation between the cells involved in 
up-regulation of collagen synthesis and those concemed with 
TGF-{31 production. This connection could occur through para-
crine and/or autocrine m echanisms. The staini.ng for TGF-{3 in 
HTS matrix surrounding the cells demonstrating increased TGF-{31 
m . RNA suggests that cytokine may persist in HTS matri..'X. This 
finding may represent a reservoir of cytokine, which would induce 
continued matrix production . These proposed mechan.isms are 
consistent with the well-described function of TGF-{3 as a fibro-
genic mediator [31 ,35,38-41]. 
T he scattered disn;bution of fibroblasts expressing TGF-{3 within 
the HTS lesions m ay indicate au tocriJ1e and paracrine m echanisms 
for excessive collagen synthesis. However, the finding that endo-
thelial cells and fibroblast-like cells close to blood vessels w ere 
strongly positive for TGF-{31 mRNA and TGF- {3 protein suggests 
an additional or alternate mechanism. Previous studies of other 
fibrotic diseases have suggested an important role for such cells in 
the pathogenesis of fibrosis [27,31,43]. Other cytokines associated 
w ith endothelial cells have been found after bum injury, which 
supports the idea that these cells are both active after bunl injury 
and significant in the pathogenesis of HTS after burn wowld 
healing [44-45]. Co-culture experiments wi.th epidennal keratino-
cytes and dennal fibroblasts have suggested that these two popu-
lations of cells may regulate expression of extracellular matrix 
proteins, such as laminin, t1u-ough reciprocal cellular interactions 
[46]. Future studies regarding co-localization and expression of 
TGF-{3 and collagen mRNA may furth er clarify the nature o f the 
relation between various populations of skin cells in HTS. 
We ",ollid like ro tl/allk Celtrix Plrmmacellricalsfo,. II, e gift of alllibodies 10 TGF-{3 . 
T I,is IIIo,.k IIIas pmtially SlipI'D/led by N IH grallls HL 28737. HL 31963, 
HL 46487, DK 42455, mId DK 46469 alld a gralll ji'OI/l ri,e Plasric SlIlge'1' 
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